2019 Grant Recipients
Grant applications were assessed by our Scientific Advisory Panel - comprised of international and national experts in the field. The panel made recommendations to the board as to who the successful applicants should be, and these were accepted unanimously.
Next steps in harnessing a novel 'tuneable' immune checkpoint to enhance the immunogenicity of anti-pancreatic ductal adenocarcinoma
Developing new immunotherapies for pancreatic cancer
Development of new radioimmunotherapy agent to selectively target and kill pancreatic cancer cells
A novel agent for imaging and treatment of pancreatic cancer
Development of a non-invasive method of early detection for pancreatic cancer patients using nanotechnology
Surgical removal of non-metastatic pancreatic cancer – a comparison of European vs